Abstract
Previously we reported that administration of IgG could inhibit tumor progression in mouse models. At the same time, we also found that some IgGs have glycosylation modifications on their Fab fragments, which may have different biological functions than non-glycosylated IgG. In this study, we employed mouse tumor models to explore the roles of two different forms of IgG, i.e. Fab-glycosylated and Fab-non-glycosylated IgG, in tumor progression. The two types of IgGs were separated with ConA absorption which could react with glycan on the Fab arm but could not access glycan on the Fc fragment. In addition, we performed cytokine array, ELISA, western blotting, immunocytochemistry and other techniques to investigate the possible mechanisms of the actions of Fab-glycosylated IgG in the models. We found that Fab-glycosylated IgG, unlike Fab-non-glycosylated IgG, did not inhibit tumor growth and metastasis in the model. On the contrary, Fab-glycosylated IgG may bind to antigen-bound IgG molecules and macrophages through the glycosidic chain on the Fab fragment to affect antigen–antibody binding and macrophage polarization, which are likely to help tumor cells to evade the immune surveillance. A new mechanism of immune evasion with Fab-glycosylated IgG playing a significant role was proposed.
Similar content being viewed by others
Abbreviations
- ConA:
-
Concanavalin A
- DSA:
-
Datura stramonium agglutinin
- ELISA:
-
Enzyme-linked immunosorbent assay
- GM-CSF:
-
Granulocyte–macrophage colony-stimulating factor
- GNA:
-
Galanthus nivalis agglutinin
- HRP:
-
Horseradish peroxidase
- ICAM-1:
-
Intercellular adhesion molecule 1
- IFN-γ:
-
Interferon gamma
- IL:
-
Interleukin
- IVIg:
-
Intravenous immunoglobulin
- LDL R:
-
Low-density lipoprotein receptor
- LPS:
-
Lipopolysaccharide
- MAA:
-
Maackia amurensis agglutinin
- MFI:
-
Mean fluorescence intensity
- MMP 9:
-
Matrix metallopeptidase 9
- MR:
-
Mannose receptor
- SNA:
-
Sambucus nigra agglutinin
- TAM:
-
Tumor-associated macrophages
- P-PE:
-
P-phycoerythrin
- PNA:
-
Peanut agglutinin
References
Poljak RJ (1975) Three-dimensional structure, function and genetic control of immunoglobulins. Nature 256(5516):373–376
Youings A, Chang SC, Dwek RA, Scragg IG (1996) Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem J 314(Pt 2):621–630
Jefferis R (2005) Glycosylation of recombinant antibody therapeutics. Biotechnol Prog 21(1):11–16. https://doi.org/10.1021/bp040016j
van de Bovenkamp FS, Hafkenscheid L, Rispens T, Rombouts Y (2016) The emerging importance of IgG Fab glycosylation in immunity. J Immunol 196(4):1435–1441. https://doi.org/10.4049/jimmunol.1502136
Borel IM, Gentile T, Angelucci J, Margni RA, Binaghi RA (1989) Asymmetrically glycosylated IgG isolated from non-immune human sera. Biochem Biophys Acta 990(2):162–164
Barrientos G, Fuchs D, Schrocksnadel K, Ruecke M, Garcia MG, Klapp BF, Raghupathy R, Miranda S, Arck PC, Blois SM (2009) Low levels of serum asymmetric antibodies as a marker of threatened pregnancy. J Reprod Immunol 79(2):201–210. https://doi.org/10.1016/j.jri.2008.11.002
Gentile T, Borel IM, Angelucci J, Miranda S, Margni RA (1992) Preferential synthesis of asymmetric antibodies in rats immunized with paternal particulate antigens. Effect on pregnancy. J Reprod Immunol 22(2):173–183
Margni RA, Perdigon G, Abatangelo C, Gentile T, Binaghi RA (1980) Immunobiological behaviour of rabbit precipitating and non-precipitating (co-precipitating) antibodies. Immunology 41(3):681–686
Huang T, Chen X, Gu H, Zhao C, Liu X, Yan M, Deng X, Zhang Z, Gu J (2016) Fractionation of Fab glycosylated immunoglobulin G with concanavalin A chromatography unveils new structural properties of the molecule. Oncotarget 7(21):31166–31176. https://doi.org/10.18632/oncotarget.9085
Zenclussen AC, Gentile T, Kortebani G, Mazzolli A, Margni R (2001) Asymmetric antibodies and pregnancy. Am J Reprod Immunol 45(5):289–294
Chen Y, Tan W, Wang C (2018) Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition. OncoTargets Ther 11:3817–3826. https://doi.org/10.2147/OTT.S168317
Mantovani A, Locati M (2013) Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler Thromb Vasc Biol 33(7):1478–1483. https://doi.org/10.1161/ATVBAHA.113.300168
Murray PJ (2017) Macrophage polarization. Annu Rev Physiol 79:541–566. https://doi.org/10.1146/annurev-physiol-022516-034339
Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549–555
Rhee I (2016) Diverse macrophages polarization in tumor microenvironment. Arch Pharm Res 39(11):1588–1596. https://doi.org/10.1007/s12272-016-0820-y
Amin R, Mourcin F, Uhel F, Pangault C, Ruminy P, Dupre L, Guirriec M, Marchand T, Fest T, Lamy T, Tarte K (2015) DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma. Blood 126(16):1911–1920. https://doi.org/10.1182/blood-2015-04-640912
Xu Q, Zhang Z, Chen Z, Zhang B, Zhao C, Zhang Y, Zhao C, Deng X, Zhou Y, Wu Y, Gu J (2019) Nonspecific immunoglobulin G is effective in preventing and treating cancer in mice. Cancer Manag Res 11:2073–2085. https://doi.org/10.2147/CMAR.S188172
Gu J, Lei Y, Huang Y, Zhao Y, Li J, Huang T, Zhang J, Wang J, Deng X, Chen Z, Korteweg C, Deng R, Yan M, Xu Q, Dong S, Cai M, Luo L, Huang G, Wang Y, Li Q, Lin C, Su M, Yang C, Zhuang Z (2015) Fab fragment glycosylated IgG may play a central role in placental immune evasion. Hum Reprod 30(2):380–391. https://doi.org/10.1093/humrep/deu323
Overdijk MB, Verploegen S, Ortiz Buijsse A, Vink T, Leusen JH, Bleeker WK, Parren PW (2012) Crosstalk between human IgG isotypes and murine effector cells. J Immunol 189(7):3430–3438. https://doi.org/10.4049/jimmunol.1200356
Fishman P, Bar-Yehuda S, Shoenfeld Y (2002) IVIg to prevent tumor metastases (review). Int J Oncol 21(4):875–880
Shoenfeld Y, Fishman P (1999) Gamma-globulin inhibits tumor spread in mice. Int Immunol 11(8):1247–1252
Li M, Gao CJ (2008) An update on beta2 integrin LFA-1 and ligand ICAM-1 signaling. Zhongguo shi yan xue ye xue za zhi 16(1):213–216
Reimers N, Zafrakas K, Assmann V, Egen C, Riethdorf L, Riethdorf S, Berger J, Ebel S, Janicke F, Sauter G, Pantel K (2004) Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells. Clin Cancer Res 10(10):3422–3428. https://doi.org/10.1158/1078-0432.CCR-03-0610
Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff TH (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 101(13):4560–4565. https://doi.org/10.1073/pnas.0400983101
Mannino MH, Zhu Z, Xiao H, Bai Q, Wakefield MR, Fang Y (2015) The paradoxical role of IL-10 in immunity and cancer. Cancer Lett 367(2):103–107. https://doi.org/10.1016/j.canlet.2015.07.009
Gercel-Taylor C, Bazzett LB, Taylor DD (2001) Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer. Gynecol Oncol 81(1):71–76. https://doi.org/10.1006/gyno.2000.6102
Kodar K, Stadlmann J, Klaamas K, Sergeyev B, Kurtenkov O (2012) Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival. Glycoconj J 29(1):57–66. https://doi.org/10.1007/s10719-011-9364-z
Canellada A, Gentile T, Dokmetjian J, Margni RA (2002) Occurrence, properties, and function of asymmetric IgG molecules isolated from non-immune sera. Immunol Investig 31(2):107–120
Wright A, Tao MH, Kabat EA, Morrison SL (1991) Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. EMBO J 10(10):2717–2723
Coloma MJ, Trinh RK, Martinez AR, Morrison SL (1999) Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1–>6) dextran antibody. J Immunol 162(4):2162–2170
Schneider D, Duhren-von Minden M, Alkhatib A, Setz C, van Bergen CA, Benkisser-Petersen M, Wilhelm I, Villringer S, Krysov S, Packham G, Zirlik K, Romer W, Buske C, Stevenson FK, Veelken H, Jumaa H (2015) Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma. Blood 125(21):3287–3296. https://doi.org/10.1182/blood-2014-11-609404
Chavele KM, Martinez-Pomares L, Domin J, Pemberton S, Haslam SM, Dell A, Cook HT, Pusey CD, Gordon S, Salama AD (2010) Mannose receptor interacts with Fc receptors and is critical for the development of crescentic glomerulonephritis in mice. J Clin Investig 120(5):1469–1478. https://doi.org/10.1172/JCI41560
Acknowledgements
This research was funded by the National Natural Science Foundation of China (81872334) and Li Ka Shing Foundation. The authors would like to thank the Laboratory Animal Center and the Center for Core Facilities of Shantou University Medical College for supporting and providing help to this research.
Author information
Authors and Affiliations
Contributions
JG coordinated the entire project; JG and QX wrote the manuscript; QX, XD, BZ, CZ, TH, YZ, and ZC performed the experiments; QX, BZ, CZ analyzed the data.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving animals were in accordance with the ethical standards of the Medical Animal Care and Welfare Committee of Shantou University Medical College (SUMC 2018-128).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Xu, Q., Deng, X., Zhang, B. et al. A study of the possible role of Fab-glycosylated IgG in tumor immunity. Cancer Immunol Immunother 70, 1841–1851 (2021). https://doi.org/10.1007/s00262-020-02809-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-020-02809-z